Eli Lilly signs $1.9B gene-editing deal with Ascidian Therapeutics

Stocks Yahoo Finance By Yahoo Finance 03 Jun 2026 14:02 1 min read

Eli Lilly signs $1.9B gene-editing deal with Ascidian Therapeutics

Eli Lilly signs $1.9B gene-editing deal with Ascidian Therapeutics

Eli Lilly signs $1.9B gene-editing deal with Ascidian Therapeutics

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.